Clinical Scorecard: Effectiveness and Safety of Electrical Cardioversion and Catheter Ablation in Pregnant Patients: A Case Study and Review of Existing Literature
At a Glance
Category
Detail
Condition
Pregnancy-associated arrhythmias
Key Mechanisms
Electrical cardioversion and catheter ablation for rhythm control
Target Population
Pregnant women with arrhythmias
Care Setting
Obstetric and cardiology settings
Key Highlights
Success rates for electrical cardioversion and catheter ablation are 89.7% and 97.5%, respectively.
Electrical cardioversion had 5 cases of preterm delivery and 2 cases of maternal-fetal mortality.
Catheter ablation had 2 cases of preterm delivery with no maternal-fetal mortality.
Atrial fibrillation was the most common arrhythmia in the cardioversion group.
AVNRT predominated in the catheter ablation cohort.
Guideline-Based Recommendations
Diagnosis
Consider electrical cardioversion or catheter ablation for arrhythmias during pregnancy.
Management
Utilize electrical cardioversion and catheter ablation as treatment options for refractory arrhythmias.
Monitoring & Follow-up
Monitor for maternal-fetal adverse events post-procedure.
Risks
Potential risks include fetal arrhythmia, preterm labor, and maternal cardiovascular instability.
Patient & Prescribing Data
Pregnant women experiencing arrhythmias
Limited pharmacological options due to Category C drug risks; electrical cardioversion and catheter ablation are viable alternatives.
Clinical Best Practices
Conduct thorough assessments of arrhythmia types and patient symptoms.
Ensure informed consent regarding the risks and benefits of procedures.
Utilize systematic reviews to guide clinical decision-making in managing arrhythmias during pregnancy.
